Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

It Is Cancer in Kate Middleton.

2.

Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.

3.

High levels of traumatic stress found in caregivers of adult cancer patients

4.

An inadvertent loss of weight may be an indication to consult a physician, according to research.

5.

Three out of ten breast cancers detected between screenings, study finds


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot